PGC‐1α is decreased in various in vivo models of neurodegenerative diseases, including Tg2576 mice (an experimental AD model, Qin et al., 2009) and mutant human α‐synuclein transgenic mice (an experimental PD model, Su et al., 2015). Here, PPARGC1A is linked to Parkinson disease.